The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
The need for speed: an update on methamphetamine addiction
Abstract
The psychostimulant methamphetamine (MA) is a highly addictive drug that has surged in popularity over the last decade in North America. A burgeoning number of clandestine drug laboratories has led to dramatic increases in MA production, which have resulted in significant public health, legal and environmental problems. Current evidence indicates that exposure to MA is neurotoxic, and neuroimaging studies confirm that long-term use in humans may lead to extensive neural damage. These physiological changes are commonly associated with persistent forms of cognitive impairment, including deficits in attention, memory and executive function. In the present review, we provide a comprehensive description of the factors relating to MA use and the major health-related consequences, with an emphasis on MA-induced psychosis. It is hoped that increased knowledge of MA abuse will provide the basis for future treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,209
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M. S., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W., & London, E. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y.-S., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602
The hippocampus and declarative memory: cognitive mechanisms and neural codes
Eichenbaum, H. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00365-5 · Cited by 477
Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons
RIPPETH, J. D., HEATON, R. K., CAREY, C. L., MARCOTTE, T. D., MOORE, D. J., GONZALEZ, R., WOLFSON, T., GRANT, I., & GROUP, T. H. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704101021 · Cited by 435
History of the Methamphetamine Problem
Anglin, M. D., Burke, C., Perrochet, B., Stamper, E., & Dawud-Noursi, S. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400221 · Cited by 434
Saunders, C., Ferrer, J. V., Shi, L., Chen, J., Merrill, G., Lamb, M. E., Leeb-Lundberg, L. M. F., Carvelli, L., Javitch, J. A., & Galli, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110035297 · Cited by 411
Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1206 · Cited by 406
A multi‐site comparison of psychosocial approaches for the treatment of methamphetamine dependence
Rawson, R. A., Marinelli‐Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., McCann, M. J., et al. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00707.x · Cited by 387 · cited 1×
“Matrix participants initially showed significantly better attendance and longer periods of drug abstinence; however, at follow up, these differences became nonsignificant.(153) Further research is underway to determine which of the many facets of this psychosocial intervention program were most effective.”
London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., Shinn, A. K., Miotto, K., Learn, J., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 384
Kuczenski, R., Segal, D., Cho, A., & Melega, W. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01308.1995 · Cited by 376
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study
Ernst, T., Chang, L., Leonido–Yee, M., & Speck, O. (2000) · Neurology · doi:10.1212/wnl.54.6.1344 · Cited by 373
NORDAHL, T. E., Salo, R. E., & Leamon, M. H. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.3.317 · Cited by 371
Integrated Treatment for Dual Disorders: A Guide to Effective Practice
Albanese, M. J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.953 · Cited by 366
Cognitive Impairment in Individuals Currently Using Methamphetamine
Simon, S. L., Domier, C., Carnell, J., Brethen, P., Rawson, R., & Ling, W. (2000) · The American Journal on Addictions · doi:10.1080/10550490050148053 · Cited by 321
Kalechstein, A. D., Newton, T. F., & Green, M. M. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.2.215 · Cited by 288
Brain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.90 · Cited by 287
Intraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Paulus, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00334-7 · Cited by 283
Sato, M., Chen, C.-C., Akiyama, K., & Otsuki, S. (1983) · PubMed · Cited by 283
Fumagalli, F., Gainetdinov, R. R., Valenzano, K. J., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04861.1998 · Cited by 266
Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence
Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.018 · Cited by 257
Higher Cortical and Lower Subcortical Metabolism in Detoxified Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., Wong, C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.383 · Cited by 249
Chang, L., Smith, L. M., LoPresti, C., Yonekura, M. L., Kuo, J., Walot, I., & Ernst, T. (2004) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2004.06.004 · Cited by 243
Partial Recovery of Brain Metabolism in Methamphetamine Abusers After Protracted Abstinence
Wang, G.-J., Volkow, N. D., Chang, L., Miller, E., Sedler, M., Hitzemann, R., Zhu, W., Logan, J., Ma, Y., & Fowler, J. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.242 · Cited by 241
Cognitive Performance of Current Methamphetamine and Cocaine Abusers
Simon, S. L., Domier, C. P., Sim, T., Richardson, K., Rawson, R. A., & Ling, W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_06 · Cited by 228
Schmitz, Y., Lee, C. J., Schmauss, C., Gonon, F., & Sulzer, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05916.2001 · Cited by 227
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users
Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., & Miller, E. N. (2002) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00004-5 · Cited by 224
Hippocampal Function in Cognition
Sweatt, J. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1795-9 · Cited by 217
Ricaurte, G. A., Seiden, L. S., & Schuster, C. R. (1984) · Brain Research · doi:10.1016/0006-8993(84)91221-6 · Cited by 212
Treatment of methamphetamine use disorders: an update
Rawson, R. A., Gonzales, R., & Brethen, P. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00256-8 · Cited by 211
Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response
Chang, L., Cloak, C., Patterson, K., Grob, C., Miller, E. N., & Ernst, T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.039 · Cited by 205
Treatment of methamphetamine abuse: research findings and clinical directions
Cretzmeyer, M., Sarrazin, M. V., Huber, D. L., Block, R. I., & Hall, J. A. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00028-x · Cited by 197
Sexual HIV risk among gay and bisexual male methamphetamine abusers
Frosch, D., Shoptaw, S., Huber, A., Rawson, R. A., & Ling, W. (1996) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(96)00098-0 · Cited by 194
Will the Methamphetamine Problem Go Away?
Rawson, R. A., Anglin, M. D., & Ling, W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_02 · Cited by 191
Inhibition of monoamine oxidase by amphetamine and related compounds
Mantle, T. J., Tipton, K. F., & Garrett, N. J. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90432-9 · Cited by 191
Ernst, T., Chang, L., Melchor, R., & Mehringer, C. M. (1997) · Radiology · doi:10.1148/radiology.203.3.9169712 · Cited by 191
Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals
Salo, R., Nordahl, T. E., Possin, K., Leamon, M., Gibson, D. R., Galloway, G. P., Flynn, N. M., Henik, A., Pfefferbaum, A., & Sullivan, E. V. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00111-7 · Cited by 188
Barr, A. M., & Phillips, A. G. (1999) · Psychopharmacology · doi:10.1007/s002130050812 · Cited by 184
Self-citationNeurotoxic methamphetamine regimen severely impairs recognition memory in rats
Schröder, N., O'Dell, S. J., & Marshall, J. F. (2003) · Synapse · doi:10.1002/syn.10210 · Cited by 179
Additive Effects of HIV and Chronic Methamphetamine Use on Brain Metabolite Abnormalities
Chang, L., Ernst, T., Speck, O., & Grob, C. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.361 · Cited by 178
Amphetamine-induced Dopamine Efflux
Khoshbouei, H., Wang, H., Lechleiter, J. D., Javitch, J. A., & Galli, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212815200 · Cited by 176
Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving
Newton, T. F., Roache, J. D., De La Garza, R., Fong, T., Wallace, C. L., Li, S.-H., Elkashef, A., Chiang, N., & Kahn, R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300979 · Cited by 164
Medications development: Successes and challenges
Vocci, F., & Ling, W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.010 · Cited by 160
A ‘crash’ course on psychostimulant withdrawal as a model of depression
Barr, A. M., Markou, A., & Phillips, A. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02086-2 · Cited by 159
Self-citationMethamphetamine abuse and emergency department utilization.
Richards, J. R., Bretz, S. W., Johnson, E. B., Turnipseed, S. D., Brofeldt, B. T., & Derlet, R. W. (1999) · Europe PMC (PubMed Central) · Cited by 157
Why is parkinsonism not a feature of human methamphetamine users?
Moszczyńska, A., Fitzmaurice, P. S., Ang, L. C., Kalasinsky, K. S., Schmunk, G. A., Peretti, F. J., Aiken, S. S., Wickham, D. J., & Kish, S. J. (2004) · Brain · doi:10.1093/brain/awh046 · Cited by 152
Abuse and Violence History of Men and Women in Treatment for Methamphetamine Dependence
Cohen, J. B., Dickow, A., Horner, K., Zweben, J. E., Balabis, J., Vandersloot, D., Reiber, C., & The Methamphetamine Treatment Project (2003) · American Journal on Addictions · doi:10.1080/10550490390240701 · Cited by 151
A Comparison of Patterns of Methamphetamine and Cocaine Use
Simon, S. L., Richardson, K., Dacey, J., Glynn, S. M., Domier, C. P., Rawson, R. A., & Ling, W. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_04 · Cited by 144
The effect of relapse on cognition in abstinent methamphetamine abusers
Simon, S. L., Dacey, J., Glynn, S., Rawson, R., & Ling, W. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.03.011 · Cited by 142
Ende, G. R., Laxer, K. D., Knowlton, R. C., Matson, G. B., Schuff, N. W., Fein, G., & Weiner, M. W. (1997) · Radiology · doi:10.1148/radiology.202.3.9051038 · Cited by 141
Brown, J. M., Hanson, G. R., & Fleckenstein, A. E. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38814-7 · Cited by 135
Ujike, H., Harano, M., Inada, T., Yamada, M., Komiyama, T., Sekine, Y., Sora, I., Iyo, M., Katsu, T., Nomura, A., et al. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500189 · Cited by 130
Rosa-Neto, P., Diksic, M., Okazawa, H., Leyton, M., Ghadirian, N., Mzengeza, S., Nakai, A., Debonnel, G., Blier, P., & Benkelfat, C. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.556 · Cited by 130
Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure
González, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B. C., Cherner, M., & Grant, I. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.04.014 · Cited by 129
Cheng, C., Hong, C., Yu, Y. W. ‐., Chen, T., Wu, H., & Tsai, S. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.07.008 · Cited by 128
Woods, S. P., Rippeth, J. D., Conover, E., Gongvatana, A., González, R., Carey, C. L., Cherner, M., Heaton, R. K., & Grant, I. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.1.35 · Cited by 127
Marek, G. J., Vosmer, G. L., & Seiden, L. S. (1990) · Brain Research · doi:10.1016/0006-8993(90)90467-p · Cited by 124
Brodie, J. D., Figueroa, E., LASKA, E. M., & Dewey, S. L. (2004) · Synapse · doi:10.1002/syn.20097 · Cited by 121
Segal, D. S., Kuczenski, R. T., O’Neil, M. L., Melega, W. P., & Cho, A. K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300247 · Cited by 117
Belcher, A. M., O’Dell, S. J., & Marshall, J. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300771 · Cited by 117
Methamphetamine self-administration by humans
Hart, C. L., Ward, A. S., Haney, M., Foltin, R. W., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130100738 · Cited by 115
Hippocampal Complexin Proteins and Cognitive Dysfunction in Schizophrenia
Sawada, K., Barr, A. M., Nakamura, M., Arima, K., Young, C. E., Dwork, A. J., Falkai, P., Phillips, A. G., & Honer, W. G. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.263 · Cited by 115
Self-citationPsychostimulant withdrawal as an inducing condition in animal models of depression
Barr, A. M., & Markou, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.012 · Cited by 112
Self-citationClinical Pharmacokinetics of Non-Opiate Abused Drugs
Busto, U., Bendayan, R., & Sellers, E. M. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916010-00001 · Cited by 111
Methamphetamine Users in Sustained Abstinence
NORDAHL, T. E., Salo, R. E., Natsuaki, Y., Galloway, G. P., Waters, C., Moore, C. D., Kile, S. J., & Buonocore, M. H. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.444 · Cited by 110
Association analysis of the DRD4 and COMT genes in methamphetamine abuse
Li, T., Chen, C. Y., Hu, X., Ball, D., Lin, S., Chen, W., Sham, P. C., Loh, E., Murray, R. M., & Collier, D. A. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30024 · Cited by 109
Methamphetamine. Stimulant of the 1990s?
Derlet, R. W., & Heischober, B. (1990) · PubMed Central · Cited by 106
Integrating treatments for methamphetamine abuse: A psychosocial perspective
Huber, A., Ling, W. W., SHOPTAW, S. J., Gulati, V., Brethen, P., & Rawson, R. A. (1997) · Journal of Addictive Diseases · doi:10.1080/10550889709511142 · Cited by 105
Early intervention in psychotic relapse.
Birchwood, M., & Spencer, E. (2001) · Clinical Psychology Review · doi:10.1016/s0272-7358(01)00105-2 · Cited by 101
Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness
Sawada, K., Young, C. E., Barr, A. M., Longworth, K., Takahashi, S., Arango, V., Mann, J. J., Dwork, A. J., Falkai, P., Phillips, A. G., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000978 · Cited by 97
Self-citationNORDAHL, T. E., Salo, R. E., Possin, K. L., Gibson, D. R., Flynn, N. M., Leamon, M. H., Galloway, G. P., Pfefferbaum, A., Spielman, D. M., Elfar Adalsteinsson, A., et al. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00088-4 · Cited by 95
Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence
Shearer, J., WODAK, A. D., Mattick, R. P., van Beek, I., Lewis, J. E., Hall, W., & Dolan, K. A. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96912898.x · Cited by 93
Circuit Parties and Patterns of Drug Use in a Subset of Gay Men
Lee, S. J., Galanter, M. S., Dermatis, H., et al. (2003) · Journal of Addictive Diseases · doi:10.1300/j069v22n04_05 · Cited by 91
Barr, A. M., Fiorino, D. F., & Phillips, A. G. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00156-2 · Cited by 90
Self-citationDecreases in Evoked Overflow of Dopamine in Rat Striatum after Neurotoxic Doses of Methamphetamine
Cass, W. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36396-7 · Cited by 89
Tenn, C. C., Kapur, S., & Fletcher, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2253-z · Cited by 87
Lang, D. J., Kopala, L. C., Vandorpe, R. A., Rui, Q., Smith, G. N., Goghari, V. M., Lapointe, J. S., & Honer, W. G. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1829 · Cited by 87
Self-citationThe methamphetamine experience: a NIDA partnership.
Hanson, G., Rau, K. S., & Fleckenstein, A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.004 · Cited by 85
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb07243.x · Cited by 84
Sekine, Y. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00321-4 · Cited by 82
Worsley, J. N., Moszczyńska, A., Falardeau, P., Kalasinsky, K. S., Schmunk, G. A., Guttman, M., Furukawa, Y., Ang, L., Adams, V. I., Reiber, G. D., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000760 · Cited by 80
Brunswick, D. J., Benmansour, S., Tejani‐Butt, S. M., & Hauptmann, M. (1992) · Synapse · doi:10.1002/syn.890110404 · Cited by 75
Elevated environmental temperature and methamphetamine neurotoxicity
Miller, D. B., & O'Callaghan, J. P. (2003) · Environmental Research · doi:10.1016/s0013-9351(02)00051-8 · Cited by 72
Sim, T., Simon, S. L., Domier, C. P., Richardson, K., Rawson, R. A., & Ling, W. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v21n01_07 · Cited by 66
Makisumi, T., Yoshida, K.-I., Watanabe, T., Tan, N., Murakami, N., & Morimoto, A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00758-4 · Cited by 65
The Challenge of Implementing and Sustaining Integrated Dual Disorders Treatment Programs
Torrey, W. C., Drake, R. E., Cohen, M. J., Fox, L., Lynde, D., Gorman, P., & Wyzik, P. F. (2002) · Community Mental Health Journal · doi:10.1023/a:1020888403586 · Cited by 63
Morita, Y., Ujike, H., Tanaka, Y., Uchida, N., Nomura, A., Ohtani, K., Kishimoto, M., Morio, A., Imamura, T., Sakai, A., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.050 · Cited by 62
Armstrong, B. D., & Noguchi, K. (2004) · NeuroToxicology · doi:10.1016/j.neuro.2004.06.003 · Cited by 61
Barr, A. M., Hofmann, C. E., Weinberg, J., & Phillips, A. G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00308-6 · Cited by 60
Self-citationSegal, D. S., Kuczenski, R. T., O’Neil, M. L., Melega, W. P., & Cho, A. K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2188-4 · Cited by 60
Gene Polymorphisms of the Mu Opioid Receptor in Methamphetamine Abusers
Ide, S., Kobayashi, H., Tanaka, K., Ujike, H., Sekine, Y., Ozaki, N., Inada, T., Harano, M., Komiyama, T., Yamada, M., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.039 · Cited by 60
Tedeschi, G., Bertolino, A., Lundbom, N. M. I., Bonavita, S., Patronas, N., Duyn, J. H., Metman, L. V., Chase, T. N., & Chiro, G. D. (1996) · Neurology · doi:10.1212/wnl.47.3.696 · Cited by 60
Methamphetamine and MDMA (Ecstasy) Neurotoxicity: 'of Mice and Men'
Itzhak, Y., & Achat‐Mendes, C. (2004) · IUBMB Life · doi:10.1080/15216540410001727699 · Cited by 59
Highly selective neurotoxins : basic and clinical applications
Kostrzewa, R. M. (1998) · Humana Press eBooks · Cited by 58
Barr, A. M., & Phillips, A. G. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00664-5 · Cited by 58
Self-citationBarr, A. M., Young, C. E., Sawada, K., Trimble, W. S., Phillips, A. G., & Honer, W. G. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03457.x · Cited by 57
Self-citationYuan, J., Callahan, B. T., McCann, U. D., & Ricaurte, G. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00339.x · Cited by 56
Itoh, K., Hashimoto, K., Shimizu, E., Sekine, Y., Ozaki, N., Inada, T., Harano, M., Iwata, N., Komiyama, T., Yamada, M., et al. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30097 · Cited by 56
Abnormal cerebral perfusion in chronic methamphetamine abusers: A study using 99mTC-HMPAO and spect
Iyo, M., Namba, H., Yanagisawa, M., Hirai, S., Yui, N., & Fukui, S. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00079-1 · Cited by 56
Life with jib: A snapshot of street youth's use of crystal methamphetamine
Bungay, V., Malchy, L. A., Buxton, J. A., Johnson, J. L., MacPherson, D., & Rosenfeld, T. (2006) · Addiction Research & Theory · doi:10.1080/16066350500270901 · Cited by 55
Olanzapine Treatment of Methamphetamine Psychosis
Misra, L. K., Kofoed, L., Oesterheld, J. R., & Richards, G. A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00023 · Cited by 53
Zhao, H., Brenneisen, R., Scholer, A., McNally, A. J., ElSohly, M. A., Murphy, T. P., & Salamone, S. J. (2001) · Journal of Analytical Toxicology · doi:10.1093/jat/25.4.258 · Cited by 53
Methamphetamine Abuse: Issues for Special Populations
Freese, T. E., Obert, J. L., Dickow, A., Cohen, J. B., & Lord, R. H. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400226 · Cited by 52
Neuromechanism of Developing Methamphetamine Psychosis: A Neuroimaging Study
Iyo, M., Sekine, Y., & Mori, N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.036 · Cited by 51
Methamphetamine-Associated Burn Injuries: A Retrospective Analysis
Danks, R. R., Wibbenmeyer, L. A., Faucher, L. D., Sihler, K. C., Kealey, G. P., Chang, P., Amelon, M., & Lewis, R. W., Jr. (2004) · Journal of Burn Care & Rehabilitation · doi:10.1097/01.bcr.0000138298.30449.aa · Cited by 50
Hashimoto, T., Hashimoto, K., Matsuzawa, D., Shimizu, E., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30164 · Cited by 48
McCarthy, W. J., Zhou, Y., Hser, Y., & Collins, C. C. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n02_04 · Cited by 46
Nishiyama, T., Ikeda, M., Iwata, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Sekine, Y., Iyo, M., Harano, M., Komiyama, T., et al. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500292 · Cited by 45
Positive association of AKT1 haplotype to Japanese methamphetamine use disorder
Ikeda, M., Iwata, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshiya, Y., Sekine, Y., Iyo, M., Harano, M., Komiyama, T., et al. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005481 · Cited by 44
Hong, C.-J., Cheng, C.-Y., Shu, L.-R. R., Yang, C.-Y., & Tsai, S. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0790-8 · Cited by 43
Gender-specific contribution of the GABAA subunit genes on 5q33 in methamphetamine use disorder
Lin, S.-K., Chen, C.-K., Ball, D., Liu, H.-C., & Loh, E.-W. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500203 · Cited by 43
Half a million Americans use methamphetamine every week
Roehr, B. (2005) · BMJ · doi:10.1136/bmj.331.7515.476 · Cited by 43
Shape changes of the corpus callosum in abstinent methamphetamine users
Oh, J. S., Lyoo, I. K., Sung, Y. H., Hwang, J., Kim, J. H., Chung, A., Park, K. S., Kim, S. J., Renshaw, P. F., & Song, I. C. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.082 · Cited by 43
Levounis, P., Galanter, M., Dermatis, H., Hamowy, A., & Leon, G. D. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n03_05 · Cited by 42
Use of MDA (The "Love Drug") and Methamphetamine in Toronto by Unsuspecting Users of Ecstasy (MDMA)
Kalasinsky, K. S., Hugel, J., & Kish, S. (2004) · Journal of Forensic Sciences · doi:10.1520/jfs2003401 · Cited by 42
Development of Immunopharmacotherapy Against Drugs of Abuse
Meijler, M. M., Matsushita, M., Wirsching, P., & Janda, K. D. (2004) · Current Drug Discovery Technologies · doi:10.2174/1570163043484851 · Cited by 41
Panenka, W. J., Khorram, B., Barr, A. M., Smith, G. N., Lang, D. J., Kopala, L. C., Vandorpe, R. A., & Honer, W. G. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.002 · Cited by 38
Self-citationStudy of Association between α‐Synuclein Gene Polymorphism and Methamphetamine Psychosis/Dependence
Kobayashi, H., Ide, S., Hasegawa, J., Ujike, H., Sekine, Y., Ozaki, N., Inada, T., Harano, M., Komiyama, T., Yamada, M., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.040 · Cited by 38
Johnson, B. A., Roache, J. D., Ait-Daoud, N., Wallace, C., Wells, L. T., & Wang, Y. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1998-0 · Cited by 33
Methamphetamine and diphenhydramine effects on the rate of cognitive processing
Mohs, R. C., Tinklenberg, J. R., Roth, W. T., & Kopell, B. S. (1978) · Psychopharmacology · doi:10.1007/bf00428024 · Cited by 33
Risperidone treatment of methamphetamine psychosis
Misra, L., & Kofoed, L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.8.1170a · Cited by 32
Matsumoto, T., YAMAGUCHI, A., Asami, T., KAMIJO, A., Iseki, E., Hirayasu, Y., & Wada, K. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01376.x · Cited by 31
DAT polymorphism and diverse clinical manifestations in methamphetamine abusers
Liu, H., Lin, S., Liu, S.-K., Chen, S.-L., Hu, C., Chang, J., & Leu, S. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200403000-00005 · Cited by 30
Koizumi, H., Hashimoto, K., Kumakiri, C., Shimizu, E., Sekine, Y., Ozaki, N., Inada, T., Harano, M., Komiyama, T., Yamada, M., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20148 · Cited by 30
Tsai, S., Cheng, C., Shu, L.-R., Yang, C.-Y., Pan, C.-W., Liou, Y., & Hong, C. (2002) · Psychiatric Genetics · doi:10.1097/00041444-200203000-00004 · Cited by 30
The Association Study of DRD2, ACE and AGT Gene Polymorphisms and Metamphetamine Dependence
Šerý, O., Vojtová, V., & Zvolský, P. (2001) · Physiological Research · doi:10.33549/physiolres.930001 · Cited by 29
Managing comorbid schizophrenia and substance abuse
Drake, R. E., & Mueser, K. T. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-996-0037-8 · Cited by 28
Barr, A. M., Song, C., Sawada, K., Young, C. E., Honer, W. G., & Phillips, A. G. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570200319x · Cited by 27
Self-citationEvidence for and Mechanism of Action of Neurotoxicity of Amphetamine Related Compounds
Lew, R., Malberg, J. E., Ricuarte, G. A., & Seiden, L. S. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-477-1_9 · Cited by 25
The role of the dopamine transporter in cocaine abuse
Izenwasser, S. (2004) · Neurotoxicity Research · doi:10.1007/bf03033312 · Cited by 24
Barr, A. M., Zis, A. P., & Phillips, A. G. (2001) · Psychopharmacology · doi:10.1007/s002130100906 · Cited by 24
Self-citationImproved Psychological Status in a Modified Therapeutic Community for Homeless MICA Men
Egelko, S., Galanter, M. S., Dermatis, H., Jurewicz, E. C., Jamison, A. L., Dingle, S., & Leon, G. D. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n02_07 · Cited by 19
Daniels, J., Wessinger, W. D., Hardwick, W. C., Li, M., Gunnell, M. G., Hall, C., Owens, S. M., & McMillan, D. E. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0299-6 · Cited by 18
Inada, T., Iijima, Y., Uchida, N., Maeda, T., IWASHITA, S., Ozaki, N., Harano, M., KOMIYAMA, T., Yamada, M., Sekine, Y., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.003 · Cited by 16
Ciano, P. D., Blaha, C. D., & Phillips, A. G. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00265-0 · Cited by 14
IWATA, N., Inada, T., Harano, M., KOMIYAMA, T., Yamada, M., Sekine, Y., Iyo, M., Sora, I., Ujike, H., & Ozaki, N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.004 · Cited by 13
The X-box binding protein 1 (XBP1) gene is not associated with methamphetamine dependence
Morita, Y., Ujike, H., Tanaka, Y., Uchida, N., Nomura, A., Otani, K., Kishimoto, M., Morio, A., Inada, T., Harano, M., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.04.014 · Cited by 12
Cited by
A review of the clinical pharmacology of methamphetamine
Cruickshank, C. C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 769
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 671
Methamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 498
Developmental Consequences of Fetal Exposure to Drugs: What We Know and What We Still Must Learn
Ross, E. J., Graham, D. L., Money, K. M., & Stanwood, G. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.147 · Cited by 476
Metadata
- Authors
- Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2006-09
- Volume
- 31
- Issue
- 5
- Pages
- 301-313
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W2103129019
- Cited by
- 434
- References
- 146
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.